================================================================================
FORM 10-Q/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Commission file number 0-20713
EntreMed, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 58-1959440
------------------------------- ------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
Suite 200
9640 Medical Center Drive
Rockville, Maryland
----------------------------------------
(Address of principal executive offices)
20850
----------
(Zip Code)
(301) 217-9858
----------------------------------------------------
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes |X| No | |
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.
Title of Each Class Shares Outstanding as of May 12, 1999
- -------------------------------------- -------------------------------------
Common Stock, Par Value $.01 Per Share 13,173,205
================================================================================
-1-
<PAGE>
EXPLANATORY NOTE:
The sole purpose of this amendment is to indicate on the cover page that
the registrant (1) has filed all reports required to be filed by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ENTREMED, INC.
(Registrant)
Date: May 20, 1999 /s/ John W. Holaday, Ph.D.
-------------------------------------
John W. Holaday, Ph.D.
Chairman of the Board, President and
Chief Executive Officer
Date: May 20, 1999 /s/ R. Nelson Campbell
-------------------------------------
R. Nelson Campbell
Chief Financial Officer
-2-
